Potassium Iodide Market Size, Share, and Growth Forecast, 2026 - 2033

The global potassium iodide market size is likely to be valued at US$0.8 billion in 2026 and is expected to reach US$1.2 billion by 2033, growing at a CAGR of 6.1% during the forecast period from 2026 to 2033, driven by increasing demand for thyroid disorder treatment, iodine deficiency prevention, and nuclear radiation emergency preparedness.

In 2025, WHO reported that more than 120 countries had eliminated iodine deficiency disorders or made substantial progress in controlling them, largely through national salt-iodization programs, supporting continued demand for iodine-based health interventions.

Driver - Rising Demand in Pharmaceuticals and Thyroid Health Management

Potassium iodide demand is increasing due to its critical role in thyroid health management, iodine supplementation, and pharmaceutical formulations. Growing awareness regarding iodine deficiency disorders and rising healthcare requirements are supporting market expansion. Increased use in diagnostic procedures and preventive healthcare further strengthens demand across developed and emerging healthcare markets.

In 2024, the World Health Organization emphasized the continuing risk of iodine deficiency associated with changing dietary patterns in parts of Europe, reinforcing the importance of adequate iodine intake. These requirements sustain demand for reliable, pharmaceutical-grade potassium iodide globally. Demand is supported by potassium iodide’s established position in public-health preparedness.

The U.S. Food and Drug Administration recognizes potassium iodide as a thyroid-blocking agent for radiation emergencies involving radioactive iodine, creating requirements for appropriate stockpiling and availability in preparedness programs. Pharmaceutical manufacturers also incorporate potassium iodide into selected formulations addressing iodine deficiency and thyroid-related needs. As healthcare systems strengthen emergency readiness and improve access to essential medicines, manufacturers are expected to maintain consistent supply, quality, and regulatory compliance.

Restraint - Competitive Threats and Market Fragmentation

The potassium iodide market faces competitive threats from alternative iodine compounds, substitute ingredients, and suppliers offering similar products across pharmaceutical and industrial applications. Market fragmentation can intensify price competition, particularly where multiple manufacturers compete on purity, consistency, delivery reliability, and regulatory compliance. Smaller producers may also compete in regional markets by offering customized grades or flexible supply arrangements. Differences in production capabilities and quality standards can make supplier selection more complex for customers.

Fragmentation is also influenced by varied end-use requirements and regional regulatory frameworks governing pharmaceutical ingredients nutritional products, and emergency preparedness supplies. Producers serving highly regulated pharmaceutical customers must demonstrate consistent quality, traceability, and documentation, which can increase operating complexity. At the same time, competition from established chemical manufacturers and specialized iodine suppliers may limit opportunities for smaller companies to secure contracts.

Opportunity - Technological Convergence and New Formulations

Technological convergence creates opportunities for potassium iodide manufacturers to develop improved formulations, delivery systems, and application-specific grades. Advances in pharmaceutical formulation can support more convenient tablets, solutions, and other dosage formats designed for accurate administration and improved stability. Potassium iodide can also benefit from formulation research focused on shelf life, dissolution, palatability, and controlled handling requirements.

In radiation preparedness, standardized dosage forms can improve readiness and distribution. Combining chemical processing expertise with pharmaceutical formulation technologies therefore offers producers opportunities to differentiate products, address specialized customer requirements, and strengthen their position across healthcare and emergency preparedness applications in markets. New formulation opportunities are particularly relevant as manufacturers seek products that meet diverse pharmaceutical, nutritional, and emergency-response requirements.

Enhanced purity, improved stability, convenient packaging, and application-specific specifications can help suppliers address stringent customer expectations. Digital quality-control technologies and advanced manufacturing systems can further improve batch consistency, traceability, and process efficiency. Collaboration among iodine producers, pharmaceutical companies, and formulation specialists may accelerate development of specialized potassium iodide products while supporting regulatory compliance.

Form Type Insights

The solid segment is expected to lead, accounting for 65% of revenue in 2026, due to its strong stability, convenient storage, and broad suitability for pharmaceutical, nutritional, and industrial applications. Its solid form is particularly suitable for tablets, powders, and iodized products, where controlled composition and longer shelf life are important. Pharmaceutical manufacturers use solid potassium iodide in thyroid-related medicines, iodine supplementation products, and radiation-emergency preparations. For example, pharmaceutical manufacturers widely utilize solid potassium iodide in thyroid medication formulations and iodine supplementation products.

Liquid is likely to represent the fastest-growing segment, supported by rising demand for ready-to-use formulations across pharmaceutical, laboratory, and specialized healthcare applications. Liquid solutions provide convenient handling, rapid preparation, and accurate dosing where precise concentrations are required. Their suitability for compounding and analytical procedures supports broader adoption among laboratories and pharmaceutical users. For instance, liquid potassium iodide solutions are used in specialized medical formulations and analytical laboratories where faster preparation and accurate dosing are required.

End-user Insights

The pharmaceuticals segment is projected to lead the market, capturing around 40% of the revenue share in 2026, supported by its established use in thyroid-related treatments, iodine supplementation, and radiation-emergency preparations. Potassium iodide serves as an important source of iodine in healthcare formulations and is particularly relevant where controlled iodine intake is required. Demand is reinforced by public-health preparedness and continued treatment of iodine-related conditions. A notable example includes potassium iodide tablets, which are used as a preventive measure during nuclear radiation emergencies and for iodine-related healthcare applications.

The food & beverages segment is likely to be the fastest-growing end-user due to increasing emphasis on iodine fortification and nutritional health. Potassium iodide can serve as an iodine source in food applications, particularly where salt iodization programs are implemented to address iodine deficiency. Growing awareness of adequate iodine intake is supporting continued demand for fortified products in regions where deficiency remains a public-health concern. Regulatory frameworks and food-fortification initiatives also encourage manufacturers to maintain consistent iodine levels in applicable products. For example, potassium iodide is added to edible salt as an iodine source in several countries to help prevent iodine deficiency disorders.

North America Potassium Iodide Market Trends

North America is likely to be a significant market for potassium iodide in 2026, supported by pharmaceutical applications, thyroid-related healthcare, iodine supplementation, laboratory use, and nuclear emergency preparedness. Demand is reinforced by established regulatory frameworks governing KI products and their use during radiological emergencies. In the U.S., the FDA guidance recognizes potassium iodide as a thyroid-blocking agent when radioactive iodine exposure occurs, while Canada maintains national preparedness measures for radiological and nuclear emergencies.

U.S. Potassium Iodide Market Trends

The U.S. is expected to dominate the regional market, accounting for approximately 80% of the market share in 2026. The FDA recognizes KI as a thyroid-blocking agent during radioactive iodine exposure. KI products are available in tablet and oral-solution forms. The FDA maintains specific guidance covering KI use during radiation emergencies. Current regulatory guidance continues to support controlled use rather than routine preventive consumption. Pharmaceutical and emergency-preparedness applications therefore remain important demand areas.

Canada Potassium Iodide Market Trends

Canada is likely to be a significant market, holding approximately 20% of the market share in 2026. Canada’s potassium iodide demand is closely linked to radiological and nuclear emergency preparedness. Health Canada states that KI may be used when public-health authorities specifically instruct populations to take it. The country maintains a coordinated federal, provincial, and local framework for nuclear emergencies. Recent preparedness guidance continues to emphasize appropriate emergency planning around nuclear facilities. KI is particularly relevant to communities located near nuclear power facilities.

Europe Potassium Iodide Market Trends

Europe is likely to be a significant market, supported by pharmaceutical applications, iodine nutrition, laboratory use, and nuclear emergency preparedness. Regulatory attention to iodine intake and radiological protection continues to influence demand across major markets. Germany maintains potassium iodide stockpiles through its federal states for potential radioactive-iodine emergencies, while the U.K. maintains specific arrangements for distributing stable iodine around nuclear sites. Germany’s food-safety authorities have also recently highlighted the importance of adequate iodine intake, supporting broader awareness of iodine-containing products.

Germany Potassium Iodide Market Trends

Germany is anticipated to dominate, accounting for around 37% of the Europe market share in 2026. Germany has a well-established potassium iodide market linked to pharmaceutical, nutritional, laboratory, and emergency-preparedness applications. All federal states maintain stocks of potassium iodide tablets for potential radioactive-iodine emergencies. Distribution is planned for potentially affected areas when authorities determine that radioactive iodine could enter the environment. This emergency framework supports institutional demand for KI products.

U.K. Potassium Iodide Market Trends

The U.K. is likely to be a significant market for hard seltzer watermelon, accounting for 15% of Europe market share in 2026, supported by pharmaceutical applications and nuclear emergency preparedness. Government guidance recognizes stable iodine tablets as a protective measure against radioactive iodine exposure. Nuclear reactor sites with potential radioactive-iodine risks maintain specific arrangements for stable iodine distribution. Authorities emphasize that tablets should be taken only when officially advised. The government also highlights the importance of correct timing for effective thyroid protection. Emergency planning therefore supports institutional procurement and preparedness demand.

Asia Pacific Potassium Iodide Market Trends

The Asia Pacific region is anticipated to be the leading region, accounting for a market share of 45% in 2026. Its potassium iodide demand is driven by pharmaceuticals, iodine nutrition, food fortification, laboratory applications, and expanding healthcare systems. The region has significant relevance for iodine-deficiency prevention because iodized salt remains an important public-health intervention. Pharmaceutical applications also benefit from growing healthcare access and demand for iodine-related products. China and India remain important markets because of their large populations and established iodine-fortification programs.

China Potassium Iodide Market Trends

China is projected to dominate the regional market, holding around a 30% share of the market in 2026, due to pharmaceutical, nutritional, laboratory, and food-fortification applications. Iodine nutrition remains important because iodized salt is a major source of dietary iodine. The country’s large healthcare and food-processing sectors create broad application potential for iodine compounds. Pharmaceutical manufacturers use iodine-based materials across healthcare applications. Potassium iodide also has relevance in laboratory and chemical processing activities.

India Potassium Iodide Market Trends

India is expected to emerge as a significant market, accounting for approximately 22% share in 2026, supported by iodine-deficiency prevention and pharmaceutical applications. The National Iodine Deficiency Disorders Control Programme promotes the use of adequately iodized salt nationwide. The program includes monitoring of iodized salt and iodine status. This creates sustained demand for iodine compounds used in food fortification. Pharmaceutical applications provide another important source of potassium iodide consumption. Indian manufacturers also supply potassium iodide in pharmaceutical and industrial grades.

The global potassium iodide market exhibits a moderately fragmented structure, driven by diverse applications across pharmaceuticals, food fortification, laboratory chemicals, nutritional products, and radiation-emergency preparedness. Competition is shaped by product quality, pharmaceutical-grade compliance, supply reliability, formulation capabilities, and regulatory certifications.

With key leaders, including Merck KGaA, Spectrum Chemical, Thermo Fisher Scientific, Nucleus Chemicals, Samrat Pharmachem, and Mediocon, the market includes both global chemical suppliers and specialized pharmaceutical-grade manufacturers. These players compete through expansion of pharmaceutical-grade product portfolios, stringent quality control, regulatory documentation, dependable supply chains, and customized packaging and formulation support.

Key Industry Developments:

• In March 2026, the Delaware Emergency Management Agency and Delaware Division of Public Health announced a free potassium iodide (KI) tablet distribution program for residents living within the 10-mile Emergency Planning Zone surrounding the Salem/Hope Creek Nuclear Generating Stations, reinforcing government preparedness initiatives and supporting demand for potassium iodide stockpiles.